The RU-486 Icon
- New Birth Control Approach Promising. // Quintessence International;Aug1982, Vol. 13 Issue 8, p905
The article presents information on a new birth control compound being developed by Etienne-Emile Baulieu, a biochemist at the University of Paris, Paris, France. According to Baulieu, the compound under development at his laboratory could lead to a birth control pill that would be taken for...
- The 'Abortion Pill': RU-486. Nathanson, Bernard // National Review;2/3/1992, Vol. 44 Issue 2, p47
The article reviews the book "The 'Abortion Pill': RU-486," by Etienne-Emile Baulieu.
- The French Pill and the ABORTION CONTROVERSY. Cole, Leonard A. // USA Today Magazine;Sep90, Vol. 119 Issue 2544, p56
Declares that the energy being exerted in trying to influence political and legal institutions regarding abortion will subside because of the technological reality of the French abortion pill. Development of the abortion pill RU486 by Dr. Etienne Emile Baulieu of Roussel-Uclaf, a French drug...
- The Abortion Pill: RU-486; A Woman's Choice (Book). Knaack, Linda // Library Journal;Dec1991, Vol. 116 Issue 21, p181
Reviews the book 'The Abortion Pill: RU-486; A Woman's Choice,' Etienne-Emile Baulieu with Mort Rosenblum.
- A French doctor defends RU 486, his embattled `abortion pill.' Nolan, C. // People;4/9/90, Vol. 33 Issue 14, p121
Excerpts from an interview with French medical researcher Dr. Etienne-Emile Baulieu, 63, a hormone specialist and developer of RU 486, the controversial `abortion pill.'
- Prized consolation. // U.S. News & World Report;10/9/89, Vol. 107 Issue 14, p13
Reports on the awarding of the prestigious Lasker Award for clinical medical research to biochemist Etienne-Emile Baulieu, the creator of the drug RU-486, known as the abortion pill.
- RU-486 collect dust on doctors' shelves. // Contemporary Sexuality;Oct2001, Vol. 35 Issue 10, p9
Only 6 percent of U.S. gynecologists have provided RU-486 the so-called abortion pill, since it won FDA approval last year, a new study shows. According to a survey by the Kaiser Family Foundation, the pill's popularity is under whelming among gynecologists who perform abortions, though it is...
- Levonorgestrel/Ethinyl Estradiol (Lybrel) for Continuous Contraception. McCarthy, Lisa; Brar, Harvinder // American Family Physician;1/15/2008, Vol. 77 Issue 2, p222
The article offers information on lybrel, a continuous-cycle oral contraceptive. It states that each tablet of this drug comprises of 90 mcg of levonorgestrel and 20 mcg of ethinyl estradiol. It mentions that this drug is not advisable for patients with a history of thromboembolic disorder,...
- Effectiveness and Failure Rates of Oral Contraceptives. Jensen, Jeffrey T. // OB/GYN Clinical Alert;Apr2011, Vol. 27 Issue 12, p90
Extended (24-day) oral contraceptive regimens are more effective than standard (21-day) cycles during typical use, and drospirenone pills had lower failure rate than other preparations.